New hope for rare hormone disorder: drug trial targets cortisol overload
NCT ID NCT06471829
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 26 times
Summary
This study tests a new drug called Lu AG13909 in 18 adults with Cushing's disease, a rare condition where the body makes too much cortisol. The main goals are to see if the drug can lower cortisol to normal levels and to check its safety. Participants will receive the drug through an IV or injection, and the dose may be adjusted over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUSHING'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AOU Citta della Salute e della Scienza di Torino
RECRUITINGTorino, 10126, Italy
-
AOU Policlinico G. Martino
RECRUITINGMessina, 98124, Italy
-
APHP - Hôpital Bicêtre
RECRUITINGLe Kremlin-Bicêtre, 94275, France
-
Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital La Conception
RECRUITINGMarseille, Europe, 13005, France
-
Azienda Ospedale Università di Padova
RECRUITINGPadova, Europe, 35128, Italy
-
Azienda Ospedaliera Universitaria Sant'Andrea
RECRUITINGRome, 00189, Italy
-
Azienda Ospedaliero-Universitaria Pisana
RECRUITINGPisa, Europe, 56124, Italy
-
Centre Hospitalier Universitaire De Lille
RECRUITINGLille, 59000, France
-
Centre Hospitalier Universitaire d'Angers
RECRUITINGAngers, Cedex 09, 49933, France
-
Debreceni Egyetem Klinikai Kozpont
RECRUITINGDebrecen, 4032, Hungary
-
Hopital Haut-Leveque
RECRUITINGPessac, 33604, France
-
Hopital Louis Pradel
RECRUITINGBron, 69677, France
-
Hospital Universitario Ramon y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital de la Santa Creu i de Sant Pau
RECRUITINGBarcelona, 08041, Spain
-
Institutul National de Endocrinologie "C.I. Parhon"
RECRUITINGBucharest, 011863, Romania
-
Ltd Aversi Clinic
RECRUITINGTbilisi, 160, Georgia
-
Ltd Tbilisi Central Hospital
RECRUITINGTbilisi, Europe, 0159, Georgia
-
Multiprofile Clinic Consilium Medulla Ltd
RECRUITINGTbilisi, Europe, 0186, Georgia
-
National Institute of Endocrinology
RECRUITINGTbilisi, Europe, 0159, Georgia
-
Northern Care Alliance, North Manchester General Hospital
RECRUITINGManchester, Europe, M8 5RB, United Kingdom
-
Semmelweis Egyetem, Belgyogyaszati es Onkologiai Klinika
RECRUITINGBudapest, 1083, Hungary
-
Spitalul Clinic Judetean Mures
RECRUITINGMures, 540139, Romania
-
Spitalul Clinic Judetean de Urgenta Cluj-Napoca
RECRUITINGClju-Napoca, 400347, Romania
-
University Hospital of Pecs
RECRUITINGPécs, 7624, Hungary
-
University of Birmingham Institute of Metabolism and Systems Research
RECRUITINGBirmingham, United Kingdom
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.